Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
47
TRNS Quote, Financials, Valuation and Earnings
Last price:
$56.56
Seasonality move
:
6.36%
Day range:
$56.73 - $59.50
52-week range:
$50.23 - $111.29
Dividend yield:
0%
P/E ratio:
46.66x
P/S ratio:
1.75x
P/B ratio:
1.79x
Volume:
95.7K
Avg. volume:
137.1K
1-year change:
-46.35%
Market cap:
$529.2M
Revenue:
$278.4M
EPS (TTM):
$1.22
Analysts' Opinion
-
Consensus RatingTranscat, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 3 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $103.67, Transcat, Inc. has an estimated upside of 82.74% from its current price of $56.73.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $95.00 representing 100% downside risk from its current price of $56.73.
Fair Value
-
According to the consensus of 4 analysts, Transcat, Inc. has 82.74% upside to fair value with a price target of $103.67 per share.
TRNS vs. S&P 500
-
Over the past 5 trading days, Transcat, Inc. has underperformed the S&P 500 by -0.73% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Transcat, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Transcat, Inc. has grown year-over-year revenues for 20 quarters straight. In the most recent quarter Transcat, Inc. reported revenues of $82.3M.
Earnings Growth
-
Transcat, Inc. earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Transcat, Inc. reported earnings per share of $0.14.
Enterprise value:
671.9M
EV / Invested capital:
--
Price / LTM sales:
1.75x
EV / EBIT:
36.31x
EV / Revenue:
2.22x
PEG ratio (5yr expected):
1.13x
EV / Free cash flow:
26.73x
Price / Operating cash flow:
21.10x
Enterprise value / EBITDA:
16.53x
Gross Profit (TTM):
$98.2M
Return On Assets:
2.86%
Net Income Margin (TTM):
3.75%
Return On Equity:
3.98%
Return On Invested Capital:
3.18%
Operating Margin:
4.86%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $242.9M | $270.6M | $302.6M | $67.8M | $82.3M | |
| Gross Profit | $74.4M | $88.8M | $98.2M | $21.2M | $26.8M | |
| Operating Income | $18.7M | $21.6M | $18.5M | $3.8M | $4M | |
| EBITDA | $30.3M | $37.6M | $40.7M | $8.2M | $10.5M | |
| Diluted EPS | $1.12 | $1.98 | $1.22 | $0.35 | $0.14 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $53.8M | $62.6M | $65.2M | $95.2M | $85.7M | |
| Total Assets | $158.3M | $186.7M | $248.2M | $323.6M | $484.9M | |
| Current Liabilities | $21.6M | $24.9M | $28.1M | $26.5M | $35.3M | |
| Total Liabilities | $77.6M | $94.4M | $110M | $54.8M | $189.5M | |
| Total Equity | $80.7M | $92.3M | $138.3M | $268.8M | $295.4M | |
| Total Debt | $49.8M | $63.5M | $67.8M | $17.7M | $143.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $27.7M | $32.4M | $39.7M | $6.8M | $12.9M | |
| Cash From Investing | -$28M | -$31.3M | -$167.6M | -$3.9M | -$87M | |
| Cash From Financing | $901K | $21.7M | $109.4M | -$1.4M | $77.2M | |
| Free Cash Flow | $17.6M | $16.9M | $25.1M | $2.9M | $8.4M | |
TRNS
Sector
Market Cap
$529.2M
$486.6M
Price % of 52-Week High
50.98%
79.79%
Dividend Yield
0%
0%
Shareholder Yield
-3.81%
1.52%
1-Year Price Total Return
-46.35%
--
Beta (5-Year)
0.776
0.534
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$58.11
200-day SMA
Sell
Level
$74.66
Bollinger Bands (100)
Sell
Level
57.49 - 79.31
Chaikin Money Flow
Sell
Level
-444.2K
20-day SMA
Sell
Level
$56.91
Relative Strength Index (RSI14)
Sell
Level
45.96
ADX Line
Sell
Level
24.41
Williams %R
Neutral
Level
-62.4064
50-day SMA
Sell
Level
$59.98
MACD (12, 26)
Buy
Level
15.87
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Sell
Level
-409.1K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.1688)
Buy
CA Score
(Annual)
Level (1.2063)
Buy
Beneish M-Score
(Annual)
Level (-2.5765)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-1.2091)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Transcat, Inc. engages in the provision of calibration and laboratory instrument services. It operates through the Service and Distribution segments. The Service segment offers calibration, repair, inspection, analytical qualifications, preventive maintenance, consulting, and other related services. The Distribution segment distributes professional grade tests, measurement, and control instrumentation. The company was founded in 1964 and is headquartered in Rochester, NY.
Stock Forecast FAQ
In the current month, TRNS has received 3 Buy ratings 1 Hold ratings, and 0 Sell ratings. The TRNS average analyst price target in the past 3 months is $103.67.
-
Where Will Transcat, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Transcat, Inc. share price will rise to $103.67 per share over the next 12 months.
-
What Do Analysts Say About Transcat, Inc.?
Analysts are divided on their view about Transcat, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Transcat, Inc. is a Sell and believe this share price will drop from its current level to $95.00.
-
What Is Transcat, Inc.'s Price Target?
The price target for Transcat, Inc. over the next 1-year time period is forecast to be $103.67 according to 4 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is TRNS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Transcat, Inc. is a Buy. 3 of 4 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of TRNS?
You can purchase shares of Transcat, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Transcat, Inc. shares.
-
What Is The Transcat, Inc. Share Price Today?
Transcat, Inc. was last trading at $56.56 per share. This represents the most recent stock quote for Transcat, Inc.. Yesterday, Transcat, Inc. closed at $56.73 per share.
-
How To Buy Transcat, Inc. Stock Online?
In order to purchase Transcat, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get TRNS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TRNS
Sector
P/E ratio
46.66x
19.19x
PEG ratio
1.13x
0.18x
P/B ratio
1.79x
1.69x
Price / LTM sales
1.75x
0.85x
Growth Metrics
TRNS
Sector
Revenue growth
21.3%
5.01%
Earnings growth
-61.86%
5.65%
Revenue (5-year growth)
9.97%
4.27%
Earnings forecast
$0.35
$0.35
Profitability
TRNS
Sector
Profitability FY 2024
$89.5M
$252.3M
Return on invested capital
3.18%
4.72%
Return on assets
2.86%
3.09%
Return on equity
3.98%
8.11%
Earnings Date
Last Earnings Date
Nov
3
Next Earnings Date
Feb
2
Estimated Next Earnings Date
Feb
2
Balance Sheet
TRNS
Sector
Total cash
$5.1M
$138.8M
Short term investments
--
$32.3M
Total assets
$395M
$1.4B
Long term debt
$143.8M
$49.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 5.4% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.78% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 8.96% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
